{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:10:07Z","timestamp":1777543807031,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,12,16]],"date-time":"2006-12-16T00:00:00Z","timestamp":1166227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jrnl Neuroimmune Pharm"],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1007\/s11481-006-9051-1","type":"journal-article","created":{"date-parts":[[2006,12,15]],"date-time":"2006-12-15T17:23:29Z","timestamp":1166203409000},"page":"93-96","source":"Crossref","is-referenced-by-count":35,"title":["Glycogen Synthase Kinase 3 Beta (GSK-3\u03b2) as a Therapeutic Target in NeuroAIDS"],"prefix":"10.1007","volume":"2","author":[{"given":"Stephen","family":"Dewhurst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay B.","family":"Maggirwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Schifitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harris A.","family":"Gelbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,12,16]]},"reference":[{"key":"9051_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/13550280600981695","volume":"12","author":"BM Ances","year":"2006","unstructured":"Ances BM, Letendre S, Buzzell M, Marquie-Beck J, Lazaretto D, Marcotte TD, Grant I, Ellis RJ (2006) Valproic acid does not affect markers of human immunodeficiency virus disease progression. J Neurovirol 12:403\u2013406","journal-title":"J Neurovirol"},{"key":"9051_CR2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1212\/WNL.53.4.782","volume":"53","author":"L Chang","year":"1999","unstructured":"Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, Miller EN (1999) Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53:782\u2013789","journal-title":"Neurology"},{"key":"9051_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pneurobio.2005.02.004","volume":"75","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ, Li F, Maiese K (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75:207\u2013246","journal-title":"Prog Neurobiol"},{"key":"9051_CR4","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1128\/AAC.48.11.4328-4331.2004","volume":"48","author":"R DiCenzo","year":"2004","unstructured":"DiCenzo R, Peterson D, Cruttenden K, Morse G, Riggs G, Gelbard H, Schifitto G (2004) Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother 48:4328\u20134331","journal-title":"Antimicrob Agents Chemother"},{"key":"9051_CR5","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1523\/JNEUROSCI.23-27-09162.2003","volume":"23","author":"H Dou","year":"2003","unstructured":"Dou H, Birusingh K, Faraci J, Gorantla S, Poluektova LY, Maggirwar SB, Dewhurst S, Gelbard HA, Gendelman HE (2003) Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 23:9162\u20139170","journal-title":"J Neurosci"},{"key":"9051_CR6","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1523\/JNEUROSCI.2164-05.2005","volume":"25","author":"H Dou","year":"2005","unstructured":"Dou H, Ellison B, Bradley J, Kasiyanov A, Poluektova LY, Xiong H, Maggirwar S, Dewhurst S, Gelbard HA, Gendelman HE (2005) Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. J Neurosci 25:8375\u20138385","journal-title":"J Neurosci"},{"key":"9051_CR7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/mcne.2002.1196","volume":"21","author":"IP Everall","year":"2002","unstructured":"Everall IP, Bell C, Mallory M, Langford D, Adame A, Rockestein E, Masliah E (2002) Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol Cell Neurosci 21: 493\u2013501","journal-title":"Mol Cell Neurosci"},{"key":"9051_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI9102","volume":"106","author":"HS Fox","year":"2000","unstructured":"Fox HS, Weed MR, Huitron-Resendiz S, Baig J, Horn TF, Dailey PJ, Bischofberger N, Henriksen SJ (2000) Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest 106:37\u201345","journal-title":"J Clin Invest"},{"key":"9051_CR9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/515693","volume":"178","author":"HE Gendelman","year":"1998","unstructured":"Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J Jr, Swindells S (1998) Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis 178:1000\u20131007","journal-title":"J Infect Dis"},{"key":"9051_CR10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.410380510","volume":"38","author":"JD Glass","year":"1995","unstructured":"Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38:755\u2013762","journal-title":"Ann Neurol"},{"key":"9051_CR11","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, Heinzel T (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969\u20136978","journal-title":"EMBO J"},{"key":"9051_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/mcne.2002.1117","volume":"20","author":"AC Hall","year":"2002","unstructured":"Hall AC, Brennan A, Goold RG, Cleverley K, Lucas FR, Gordon-Weeks PR, Salinas PC (2002) Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol Cell Neurosci 20:257\u2013270","journal-title":"Mol Cell Neurosci"},{"key":"9051_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI10553","volume":"106","author":"DL Kolson","year":"2000","unstructured":"Kolson DL, Gonzalez-Scarano F (2000) HIV and HIV dementia. J Clin Invest 106:11\u201313","journal-title":"J Clin Invest"},{"key":"9051_CR14","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","volume":"22","author":"OH Kramer","year":"2003","unstructured":"Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Gottlicher M (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 22:3411\u20133420","journal-title":"EMBO J"},{"key":"9051_CR15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","volume":"366","author":"G Lehrman","year":"2005","unstructured":"Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM (2005) Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366:549\u2013555","journal-title":"Lancet"},{"key":"9051_CR16","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1097\/01.aids.0000244208.49123.1b","volume":"20","author":"SL Letendre","year":"2006","unstructured":"Letendre SL, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I (2006) Lithium improves HIV-associated neurocognitive impairment. AIDS 20:1885\u20131888","journal-title":"AIDS"},{"key":"9051_CR17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1471-4159.1999.0730578.x","volume":"73","author":"SB Maggirwar","year":"1999","unstructured":"Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S (1999) HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 73:578\u2013586","journal-title":"J Neurochem"},{"key":"9051_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/med.10011","volume":"22","author":"A Martinez","year":"2002","unstructured":"Martinez A, Castro A, Dorronsoro I, Alonso M (2002) Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. Med Res Rev 22:373\u2013384","journal-title":"Med Res Rev"},{"key":"9051_CR19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1212\/WNL.43.3_Part_1.509","volume":"43","author":"DJ Meyerhoff","year":"1993","unstructured":"Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G (1993) Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43:509\u2013515","journal-title":"Neurology"},{"key":"9051_CR20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-6273(02)00764-X","volume":"35","author":"S Murase","year":"2002","unstructured":"Murase S, Mosser E, Schuman EM (2002) Depolarization drives beta-Catenin into neuronal spines promoting changes in synaptic structure and function. Neuron 35:91\u2013105","journal-title":"Neuron"},{"key":"9051_CR21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1523\/JNEUROSCI.22-03-00757.2002","volume":"22","author":"W Nishimura","year":"2002","unstructured":"Nishimura W, Yao I, Iida J, Tanaka N, Hata Y (2002) Interaction of synaptic scaffolding molecule and Beta-catenin. J Neurosci 22:757\u2013765","journal-title":"J Neurosci"},{"key":"9051_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrn1036","volume":"4","author":"M Packard","year":"2003","unstructured":"Packard M, Mathew D, Budnik V (2003) Wnts and TGF beta in synaptogenesis: old friends signalling at new places. Nat Rev Neurosci 4:113\u2013120","journal-title":"Nat Rev Neurosci"},{"key":"9051_CR23","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734\u201336741","journal-title":"J Biol Chem"},{"key":"9051_CR24","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1074\/jbc.M309325200","volume":"279","author":"R Rao","year":"2004","unstructured":"Rao R, Hao CM, Breyer MD (2004) Hypertonic stress activates glycogen synthase kinase 3beta-mediated apoptosis of renal medullary interstitial cells, suppressing an NFkappaB-driven cyclooxygenase-2-dependent survival pathway. J Biol Chem 279:3949\u20133955","journal-title":"J Biol Chem"},{"key":"9051_CR25","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1128\/MCB.23.13.4649-4662.2003","volume":"23","author":"JF Sanchez","year":"2003","unstructured":"Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, Maggirwar SB (2003) Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling. Mol Cell Biol 23:4649\u20134662","journal-title":"Mol Cell Biol"},{"key":"9051_CR26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000204294.28189.03","volume":"66","author":"G Schifitto","year":"2006","unstructured":"Schifitto G, Peterson DR, Zhong J, Ni H, Cruttenden K, Gaugh M, Gendelman HE, Boska M, Gelbard H (2006) Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report. Neurology 66:919\u2013921","journal-title":"Neurology"},{"key":"9051_CR27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1212\/WNL.56.1.112","volume":"56","author":"B Stankoff","year":"2001","unstructured":"Stankoff B, Tourbah A, Suarez S, Turell E, Stievenart JL, Payan C, Coutellier A, Herson S, Baril L, Bricaire F, Calvez V, Cabanis EA, Lacomblez L, Lubetzki C (2001) Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology 56:112\u2013115","journal-title":"Neurology"},{"key":"9051_CR28","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1111\/j.1460-9568.2006.04813.x","volume":"23","author":"Z Sui","year":"2006","unstructured":"Sui Z, Sniderhan LF, Fan S, Kazmierczak K, Reisinger E, Kovacs AD, Potash MJ, Dewhurst S, Gelbard HA, Maggirwar SB (2006) Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. Eur J Neurosci 23:2623\u20132634","journal-title":"Eur J Neurosci"},{"key":"9051_CR29","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1542\/peds.101.3.e7","volume":"101","author":"VJ Tepper","year":"1998","unstructured":"Tepper VJ, Farley JJ, Rothman MI, Houck DL, Davis KF, Collins-Jones TL, Wachtel RC (1998) Neurodevelopmental\/neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir. Pediatrics 101:E7","journal-title":"Pediatrics"},{"key":"9051_CR30","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1046\/j.0953-816x.2001.01572.x","volume":"13","author":"N Tong","year":"2001","unstructured":"Tong N, Sanchez JF, Maggirwar SB, Ramirez SH, Guo H, Dewhurst S, Gelbard HA (2001) Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci 13:1913\u20131922","journal-title":"Eur J Neurosci"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-006-9051-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-006-9051-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-006-9051-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T16:05:00Z","timestamp":1559405100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-006-9051-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["9051"],"URL":"https:\/\/doi.org\/10.1007\/s11481-006-9051-1","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,16]]}}}